Co-Diagnostics, Inc.

CODX

$0.3748

Name : Co-Diagnostics, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $18,294,182.00

EPSttm : -1.15

Co-Diagnostics, Inc.

$0.3748

1.37%

$0.0052

Float Short %

1.85

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.11

EPS Last/This Y

0.52

EPS This/Next Y

0.44

Price

0.37

Target Price

Analyst Recom

Performance Q

33.05

Relative Volume

0.15

Beta

0.95

Ticker: CODX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	CODX	0.314	0.00	0.00	1399
2025-09-09	CODX	0.3155	0.00	0.00	1400
2025-09-10	CODX	0.3075	0.00	999.99	1607
2025-09-11	CODX	0.3389	0.00	0.00	1612
2025-09-12	CODX	0.3547	0.00	0.00	1642
2025-09-15	CODX	0.3596	0.00	0.00	1560
2025-09-16	CODX	0.68	0.00	0.15	1590
2025-09-17	CODX	0.4171	0.1515821708064	0.29732065687122	6769
2025-09-18	CODX	0.44	0.12	0.17	7320
2025-09-22	CODX	0.42	0.11	0.02	5797
2025-09-23	CODX	0.4011	0.10	0.59	5970
2025-09-24	CODX	0.4163	0.10	0.20	6154
2025-09-25	CODX	0.3821	0.10	0.91	6270
2025-09-26	CODX	0.3821	0.12	0.05	6555
2025-09-29	CODX	0.3701	0.10	0.00	4729
2025-09-30	CODX	0.3431	0.10	0.19	4739
2025-10-01	CODX	0.3576	0.11	0.07	5102
2025-10-02	CODX	0.3624	0.10	0.00	5690
2025-10-03	CODX	0.3826	0.10	0.12	5779
2025-10-06	CODX	0.3847	0.08	0.02	5386
2025-10-07	CODX	0.37	0.08	0.66	5661
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	CODX	0.31	52.6	-	-0.67
2025-09-09	CODX	0.32	52.6	-	-0.67
2025-09-10	CODX	0.31	52.6	-	-0.67
2025-09-11	CODX	0.34	52.6	-	-0.67
2025-09-12	CODX	0.34	52.6	-	-0.67
2025-09-15	CODX	0.36	52.6	-	-0.67
2025-09-16	CODX	0.64	52.6	-	-0.67
2025-09-17	CODX	0.42	52.6	-	-0.67
2025-09-18	CODX	0.44	52.6	-	-0.67
2025-09-19	CODX	0.44	52.6	-	-0.67
2025-09-22	CODX	0.42	52.6	-	-0.67
2025-09-23	CODX	0.40	52.6	-	-0.67
2025-09-24	CODX	0.42	52.6	-	-0.67
2025-09-25	CODX	0.38	52.6	-	-0.67
2025-09-26	CODX	0.38	52.6	-	-0.72
2025-09-29	CODX	0.37	46.5	-	-0.72
2025-09-30	CODX	0.34	46.5	-	-0.72
2025-10-01	CODX	0.36	46.5	-	-0.72
2025-10-02	CODX	0.36	46.5	-	-0.72
2025-10-03	CODX	0.38	46.5	-	-0.72
2025-10-06	CODX	0.38	46.5	-	-0.72
2025-10-07	CODX	0.37	46.5	-	-0.72
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	CODX	0.00	-11.99	1.46
2025-09-09	CODX	0.00	-11.99	1.46
2025-09-10	CODX	0.00	-11.99	1.46
2025-09-11	CODX	0.00	-11.99	3.88
2025-09-12	CODX	0.00	-11.99	3.88
2025-09-15	CODX	0.00	-11.97	3.88
2025-09-16	CODX	0.00	-11.97	3.88
2025-09-17	CODX	0.00	-11.97	3.88
2025-09-18	CODX	0.00	-11.97	3.88
2025-09-19	CODX	0.00	-11.97	3.88
2025-09-22	CODX	0.00	-9.81	4.66
2025-09-23	CODX	0.00	-9.81	4.66
2025-09-24	CODX	0.00	-9.81	3.72
2025-09-25	CODX	0.00	-9.81	2.17
2025-09-26	CODX	0.00	-9.81	2.17
2025-09-29	CODX	0.00	25.40	1.85
2025-09-30	CODX	0.00	25.40	1.85
2025-10-01	CODX	0.00	25.40	1.85
2025-10-02	CODX	0.00	25.40	1.85
2025-10-03	CODX	0.00	25.40	1.85
2025-10-06	CODX	0.00	4.40	1.85
2025-10-07	CODX	0.00	4.40	1.85
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-0.23

Avg. EPS Est. Current Quarter

-0.17

Avg. EPS Est. Next Quarter

-0.13

Insider Transactions

Institutional Transactions

4.4

Beta

0.95

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

98.2

Max Drawdown 5-Year %

-98.8

Target Price

P/E

Forward P/E

PEG

P/S

31.65

P/B

0.33

P/Free Cash Flow

EPS

-1.12

Average EPS Est. Cur. Y

-0.72

EPS Next Y. (Est.)

-0.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6321

Relative Volume

0.15

Return on Equity vs Sector %

-112.7

Return on Equity vs Industry %

-106.1

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.05

EBIT Estimation

Co-Diagnostics, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 132

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is based in Salt Lake City, Utah.

stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today

news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance

stock history CODX – Co-Diagnostics, Inc. invest stock market

stock prices CODX premarket after hours

ticker CODX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CODX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y